$212.5 Million
Akouos, Inc.
Initial Public Offering
Active Bookrunner
$96.0 Million
Keros Therapeutics
Initial Public Offering
Active Bookrunner
$147.6 Million
Harmony Biosciences Holdings, Inc.
Initial Public Offering
Active Bookrunner
$103.5 Million
Graybug Vision, Inc.
Initial Public Offering
Active Bookrunner
$98.3 Million
Oncorus, Inc.
Initial Public Offering
Active Bookrunner
$92.0 Million
Oyster Point Pharma, Inc.
Initial Public Offering
Active Bookrunner
$86.3 Million
NextCure, Inc.
Initial Public Offering
Left Bookrunner
$400.8 Million
BridgeBio Pharma, Inc.
Initial Public Offering
Passive Bookrunner
$201.3 Million
IGM Biosciences, Inc.
Initial Public Offering
Active Bookrunner
$60.7 Million
Bicycle Therapeutics Limited
Initial Public Offering
Active Bookrunner
Subscribe to Biopharma

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.